Company Filing History:
Years Active: 2015-2020
Title: Seok Hun Woo: Innovator in Pharmaceutical Chemistry
Introduction
Seok Hun Woo is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address viral infections. With a total of 2 patents, his work showcases a commitment to innovation and efficiency in drug development.
Latest Patents
One of his latest patents is the "Preparation method of intermediate for oxazolidinone derivative." This patent discloses a method for preparing an intermediate that enables the production of 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine at high yield and purity. This method demonstrates high preparation efficiency under optimal processing conditions, making it suitable for industrial mass production. Another notable patent is for "Phenyl-isoxazole derivatives and preparation process thereof." This patent describes a phenyl-isoxazole derivative compound that is useful in treating viral infections, particularly influenza virus infections. It also includes a preparation method and a pharmaceutical composition that incorporates the compound as an active ingredient.
Career Highlights
Seok Hun Woo has worked with notable companies in the pharmaceutical industry, including St Pharm Co., Ltd. and Il-Yang Pharm Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Seok Hun Woo has collaborated with talented individuals such as YunHee Choi and Hong Jun Kim. These collaborations have likely enhanced his research and development efforts, leading to successful innovations in the pharmaceutical field.
Conclusion
Seok Hun Woo is a dedicated inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of viral infections. His innovative patents and collaborations reflect his commitment to improving healthcare through effective drug development.